Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J. Brenner, Michael D. Kappelman, Walter Reinisch et al.|Gastroenterology|2020Cited by 692
Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE studyAnnick Moens, Marc Ferrante, C. Janneke van der Woude et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 137
Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping dataAlberto Romagnoni, Anthony Croft, Simon Jégou et al.|Scientific Reports|2019Cited by 106
A Method to Exploit the Structure of Genetic Ancestry Space to Enhance Case-Control StudiesCorneliu Bodea, Gillian Mahy, Benjamin M. Neale et al.|The American Journal of Human Genetics|2016Cited by 26